<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Research Results in Biomedicine</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2313-8955-2016-2-4-37-42</article-id><article-id pub-id-type="publisher-id">868</article-id><article-categories><subj-group subj-group-type="heading"><subject>Archive categories</subject></subj-group></article-categories><title-group><article-title>JUSTIFICATION AND DEVELOPMENT OF THE GRANULATED DOSAGE FORM FOR THE PREVENTION OF ATHEROSCLEROSIS AND NON-ALCOHOLIC STEATOHEPATOSIS</article-title><trans-title-group xml:lang="en"><trans-title>JUSTIFICATION AND DEVELOPMENT OF THE GRANULATED DOSAGE FORM FOR THE PREVENTION OF ATHEROSCLEROSIS AND NON-ALCOHOLIC STEATOHEPATOSIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Kuzmicheva</surname><given-names>Oksana A.</given-names></name><name xml:lang="en"><surname>Kuzmicheva</surname><given-names>Oksana A.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Zhilyakova</surname><given-names>Elena T.</given-names></name><name xml:lang="en"><surname>Zhilyakova</surname><given-names>Elena T.</given-names></name></name-alternatives><email>ezhilyakova@bsu.edu.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Tsvetkova</surname><given-names>Zoya E.</given-names></name><name xml:lang="en"><surname>Tsvetkova</surname><given-names>Zoya E.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Vasilyev</surname><given-names>Georgy V.</given-names></name><name xml:lang="en"><surname>Vasilyev</surname><given-names>Georgy V.</given-names></name></name-alternatives><email>vasilyev@bsu.edu.ru</email></contrib></contrib-group><pub-date pub-type="epub"><year>2016</year></pub-date><volume>2</volume><issue>4</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2016/4/Медицина_и_фармация-37-42.pdf" /><abstract xml:lang="ru"><p>Atherosclerosis and nonalcoholic steatohepatosis are pathologies, which most often develop in both the elderly and senile age. According to the scientific literature, these pathologies have a similar pathogenesis, but, despite this, the pharmaceutical market of Russia is scarce of drugs aimed at their complex treatment. Taking into account the risk of polypharmacy in elderly patients, the development of the combined medicine in the form of pellets, aimed at prevention of non-alcoholic steatogepatosis and atherosclerosis, is relevant. The article gives the theoretical justification for the use of methionine, an extract from the fruit of Silybum marianum and vitamin B12 as a component of comprehensive geriatric drug action. The choice of auxiliary substances, the composition and concentration of humectant are experimentally substantiated. In the result, the composition of the pellet form for the treatment and prevention of non-alcoholic steatogepatosis and atherosclerosis was theoretically and experimentally proved.</p></abstract><trans-abstract xml:lang="en"><p>Atherosclerosis and nonalcoholic steatohepatosis are pathologies, which most often develop in both the elderly and senile age. According to the scientific literature, these pathologies have a similar pathogenesis, but, despite this, the pharmaceutical market of Russia is scarce of drugs aimed at their complex treatment. Taking into account the risk of polypharmacy in elderly patients, the development of the combined medicine in the form of pellets, aimed at prevention of non-alcoholic steatogepatosis and atherosclerosis, is relevant. The article gives the theoretical justification for the use of methionine, an extract from the fruit of Silybum marianum and vitamin B12 as a component of comprehensive geriatric drug action. The choice of auxiliary substances, the composition and concentration of humectant are experimentally substantiated. In the result, the composition of the pellet form for the treatment and prevention of non-alcoholic steatogepatosis and atherosclerosis was theoretically and experimentally proved.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>nonalcoholic steatogepatosis</kwd><kwd>atherosclerosis</kwd><kwd>granules</kwd><kwd>methionine</kwd><kwd>geriatric</kwd></kwd-group><kwd-group xml:lang="en"><kwd>nonalcoholic steatogepatosis</kwd><kwd>atherosclerosis</kwd><kwd>granules</kwd><kwd>methionine</kwd><kwd>geriatric</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>1. Balakina M. V., Okhotnikova V. F. Granules as a Promising Dosage Form. The Issues of Biological, Medical and Pharmaceutical Chemistry. 2013. №5. Pp. 29-30.</mixed-citation></ref><ref id="B2"><mixed-citation>2. Burkov S.G., Artyunov A.T., Egorova N.V. Efficacy of Gepabene Drug in the Treatment of Fatty Liver Disease. Farmateka. Gastroenterology, Hepatology. 2010. №15 (209): 87-92.</mixed-citation></ref><ref id="B3"><mixed-citation>3. Elnikov R.S., Smakhtin M.Yu. Bystrova N.A. The Protective Effect of Methionine and Vitamins Involved in the Metabolism of Sulfhydryl and Methyl Groups, with Toxic Liver Injury. Kursk scientific-practical herald &amp;quot;Human and his health&amp;quot;. 2011. №3. Pp. &amp;nbsp;20-23.</mixed-citation></ref><ref id="B4"><mixed-citation>4. Zhilyakova E.T., Tsvetkova Z.E., Novikova M.Yu., Kuzmicheva O.A., Ivanova L.L. Determination of methionine substance technological characteristics for developing granular formulation on its foundations: Young Scientist. 2016. №19 (123). Pp. &amp;nbsp;152-155.</mixed-citation></ref><ref id="B5"><mixed-citation>5. Zhilyakova E.T., Tsvetkova Z.E. Optimization of Extraction Technique of Flavolignans Complex of Medicinal Plants. Pharmaceutical Cluster as the Integration of Science, Education and Industry: proceedings of the 5th International Scientific and Practical teleconference, Belgorod, 2015: 173-176.</mixed-citation></ref><ref id="B6"><mixed-citation>6. Zvenigorodskaya L.A., Cherkashina E. A. The Use of Hepatoprotectors in the Treatment of Hepatic Nonalcoholic Fatty Liver Disease. Farmateka. To the VI National Congress of Physicians, 2011. №15 (228). Pp. 58-63.</mixed-citation></ref><ref id="B7"><mixed-citation>7. Nikitina N.V., Hadjieva Z.D., Lezhneva L.P., Tigiev Z.B. A Technological Research into the Use of Complexes of Biologically Active Substances of Some Plants in the Composition of the Granules. Basic Research. 2010 №11. Pp. &amp;nbsp;145-151.</mixed-citation></ref><ref id="B8"><mixed-citation>8. Federal State Statistics Service, URL: http://www.gks.ru/ demography / #. (date of access: August 20, 2016).</mixed-citation></ref><ref id="B9"><mixed-citation>9. Tsokalo I. E., Zaitsev A. I. The Development of Phytocomposition in the Form of Granules Containing the Extract of Echinacea Purpurea and Succinic Acid. Current Issues of Pharmaceutical and Medical Science and Practice. 2011. Vol. 24. №1. Pp. 114-117.</mixed-citation></ref><ref id="B10"><mixed-citation>10. Schekatykhyna A.S. Vlasova T.M., Kurchenko V.P. Production of Biologically Active Substances from the Seeds of Milk Thistle (Silibum marianum (L.)). Proceedings BSU, 2008. Vol.3. p.1. Pp. 218-229.</mixed-citation></ref><ref id="B11"><mixed-citation>11. Yarygina V. N.&amp;nbsp; Guide on Gerontology and Geriatrics: Vol. 1. Fundamentals of Gerontology. General Geriatrics. Moscow, GEOTARMedia. 2010. 720 p.</mixed-citation></ref><ref id="B12"><mixed-citation>12. Anstee QM., Day CP&amp;nbsp; S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility. Journal of Hepatology. 2012. Vol. 57. Issue 5. Pp. 1097-1109.</mixed-citation></ref><ref id="B13"><mixed-citation>&amp;nbsp;</mixed-citation></ref></ref-list></back></article>